Author

D. Parker Suttle

Observed names: D P Suttle, D Parker Suttle, D. P. Suttle, D.P. Suttle, D.Parker Suttle, Suttle, D. P.

Observed institutions: St. Jude Children's Research Hospital, United States Department of Veterans Affairs, University of Tennessee Health Science Center, The University of Texas at San Antonio Health Science Center, Veterans Health Administration, Audie L. Murphy Memorial VA Hospital, University of Illinois Chicago, Memphis VA Medical Center, Stanford Medicine, Indiana University Indianapolis, Indiana University School of Medicine, University of Tennessee at Knoxville, The University of Texas at Austin, Stanford University

OpenAlex ID: A5088198473

Purification from hamster cells of the multifunctional protein that initiates de novo synthesis of pyrimidine nucleotides.

1977 · P F Coleman, D P Suttle, et al. · Journal of Biological Chemistry · 265

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26

1988 · Mary K. Danks, Carla A. Schmidt, et al. · Biochemistry · 221

Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.

1987 · W T Beck, M C Cirtain, et al. · PubMed · 182

Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.

1991 · B Y Bugg, M K Danks, et al. · Proceedings of the National Academy of Sciences · 159

Inhibition of DNA Topoisomerase IIα Gene Expression by the p53 Tumor Suppressor

1997 · Qingjian Wang, Gerard P. Zambetti, et al. · Molecular and Cellular Biology · 153

Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA.

1993 · A V Gudkov, C R Zelnick, et al. · Proceedings of the National Academy of Sciences · 136

Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells.

1993 · M K Danks, M R Warmoth, et al. · PubMed · 86

Cloning of cDNA sequences of human adenosine deaminase.

1983 · D A Wiginton, G S Adrian, et al. · Proceedings of the National Academy of Sciences · 81

Molecular cloning and nucleotide sequence for the complete coding region of human UMP synthase.

1988 · D P Suttle, B Y Bugg, et al. · Proceedings of the National Academy of Sciences · 69

Coordinate overproduction of orotate phosphoribosyltransferase and orotidine-5'-phosphate decarboxylase in hamster cells resistant to pyrazofurin and 6-azauridine.

1979 · D.P. Suttle, G.R. Stark · Journal of Biological Chemistry · 65

PDF

Resistance of Mammalian Tumor Cells to Inhibitors of DNA Topoisomerase II

1994 · William T. Beck, Mary K. Danks, et al. · Advances in pharmacology · 41

Initiation factor 3 requirement for the formation of initiation complexes with synthetic oligonucleotides

1973 · D.Parker Suttle, Michael A. Haralson, et al. · Biochemical and Biophysical Research Communications · 41

Amplification of the UMP synthase gene and enzyme overproduction in pyrazofurin-resistant rat hepatoma cells. Molecular cloning of a cDNA for UMP synthase.

1984 · J J Kanalas, D P Suttle · Journal of Biological Chemistry · 33

Ras stimulates DNA topoisomerase IIα through MEK: A link between oncogenic signaling and a therapeutic target

1999 · Guan Chen, Dennis Templeton, et al. · Oncogene · 32

The effects of initiation factor 3 on the formation of 30S initiation complexes with synthetic and natural messengers

1974 · D.Parker Suttle, Joanne M. Ravel · Biochemical and Biophysical Research Communications · 23

Altered DNA topoisomerase II in multidrug resistance

1993 · William T. Beck, Mary K. Danks, et al. · Cytotechnology · 22

The effects of initiation factors IF‐1 and IF‐3 on the dissociation of escherichia coli 70 S ribosomes

1979 · Diane Dottavio-Martin, D.Parker Suttle, et al. · FEBS Letters · 21

PDF

Synthesis, Biological Evaluation and Modeling Studies of New Pyrido[3,4-b] indole Derivatives as Broad-Spectrum Potent Anticancer Agents

2017 · Shivaputra A Patil, James K Addo, et al. · Drug Designing Open Access · 19

Nuclear Factor-Y Binding to the Topoisomerase IIα Promoter Is Inhibited by Both the p53 Tumor Suppressor and Anticancer Drugs

2003 · Ashish A Joshi, Zhong Wu, et al. · Molecular Pharmacology · 18

Analysis of UMP synthase gene and mRNA structure in hereditary orotic aciduria fibroblasts.

1988 · J K Winkler, D P Suttle · PubMed · 16

Increased levels of UMP synthase protein and mRNA in pyrazofurin-resistant rat hepatoma cells.

1983 · D P Suttle · Journal of Biological Chemistry · 14

Catalytic inhibition of DNA topoisomerase II by N-benzyladriamycin (AD 288)

2000 · Leonard Lothstein, D.Parker Suttle, et al. · Biochemical Pharmacology · 13

Localization of the gene for uridine monophosphate synthase to human chromosome region 3q13 by in situ hybridization

1989 · Mazin B. Qumsiyeh, Marcus B. Valentine, et al. · Genomics · 13

Characterization of pyrazofurin-resistant HeLa cells with amplification of UMP synthase gene

1985 · John J. Kanalas, John J. Hutton, et al. · Somatic Cell and Molecular Genetics · 11

[18] Purification of a multifunction protein bearing carbamyl-phosphate synthase, aspartate transcarbamylase, and dihydroorotase enzyme activities from mutant hamster cells

1978 · Patrick F. Coleman, D. Parker Suttle, et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 10

Works count: 39

Citation count: 1,778

H-index: 18

I10-index: 25